Welcome to CDC Stacks | Continuing Effectiveness of Serogroup A Meningococcal Conjugate Vaccine, Chad, 2013 - 26666 | Emerging Infectious Diseases
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Continuing Effectiveness of Serogroup A Meningococcal Conjugate Vaccine, Chad, 2013
Filetype[PDF - 498.63 KB]


Details:
No Related Documents.
You May Also Like:
  1. Molecular Characterization of Invasive Meningococcal Isolates from Countries in the African Meningitis Belt before Introduction of a Serogroup A Conjugate Vaccine
    Personal Author:
    Caugant, Dominique A.; Kristiansen, Paul A.; Wang, Xin; Mayer, Leonard W.; Taha, Muhamed-Kheir; Ouédraogo, Rasmata; Kandolo, Denis; Bougoudogo, Flabou; Sow, Samba; Bonte, Laurence;
    Published:
    Sep 27 2012
    Source:
    PLoS One. 7(9).
    Description:
    Background : The serogroup A conjugate meningococcal vaccine, MenAfriVac, was introduced in mass vaccination campaigns in December 2010 in Burkina Faso, Mali and Niger. In the coming years, vaccination will be extended to other African countries at r...
    File Type:
    Filetype[PDF - 256.13 KB]
  2. Persistent low carriage of serogroup A Neisseria meningitidis two years after mass vaccination with the meningococcal conjugate vaccine, MenAfriVac
    Personal Author:
    Kristiansen, Paul A; Ba, Absatou Ky; Ouédraogo, Abdoul-Salam; Sanou, Idrissa; Ouédraogo, Rasmata; Sangaré, Lassana; Diomandé, Fabien; Kandolo, Denis; Saga, Inger Marie; Misegades, Lara; Clark, Thomas A; Préziosi, Marie-Pierre; Caugant, Dominique A;
    Published:
    Dec 4 2014
    Source:
    BMC Infect Dis. 14(1).
    Description:
    Background : The conjugate vaccine against serogroup A Neisseria meningitidis (NmA), MenAfriVac, is currently being introduced throughout the African meningitis belt. In repeated multicentre cross-sectional studies in Burkina Faso we demonstrated a s...
    File Type:
    Filetype[PDF - 696.37 KB]
  3. Phenotypic and genotypic characterization of meningococcal carriage and disease isolates in Burkina Faso after mass vaccination with a serogroup a conjugate vaccine
    Personal Author:
    Kristiansen, Paul A; Ba, Absatou Ky; Sanou, Idrissa; Ouédraogo, Abdoul-Salam; Ouédraogo, Rasmata; Sangaré, Lassana; Diomandé, Fabien; Kandolo, Denis; Thomas, Jennifer Dolan; Clark, Thomas A; LaForce, Marc; Caugant, Dominique A;
    Published:
    Aug 02 2013
    Source:
    BMC Infect Dis. 2013; 13:363.
    Description:
    Background : The conjugate vaccine against serogroup A Neisseria meningitidis (NmA), MenAfriVac, was first introduced in mass vaccination campaigns of the 1-29-year-olds in Burkina Faso in 2010. The aim of this study was to genetically characterize m...
    File Type:
    Filetype[PDF - 300.64 KB]
  4. Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data
    Personal Author:
    Novak, Ryan T; Kambou, Jean Ludovic; Diomandé, Fabien V K; Tarbangdo, Tiga F; Ouédraogo-Traoré, Rasmata; Sangaré, Lassana; Lingani, Clement; Martin, Stacey W; Hatcher, Cynthia; Mayer, Leonard W; LaForce, F Marc; Avokey, Fenella; Djingarey, Mamoudou H; Messonnier, Nancy E; Tiendrébéogo, Sylvestre R; Clark, Thomas A;
    Published:
    Jul 18 2012
    Source:
    Lancet Infect Dis. 12(10):757-764.
    Description:
    Background : An affordable, highly immunogenic Neisseria meningitidis serogroup A meningococcal conjugate vaccine (PsA–TT) was licensed for use in sub-Saharan Africa in 2009. In 2010, Burkina Faso became the first country to implement a national pr...
    File Type:
    Filetype[PDF - 604.42 KB]
  5. First Use of a Serogroup B Meningococcal Vaccine in the US in Response to a University Outbreak
    Personal Author:
    McNamara, Lucy A.; Shumate, Alice M.; Johnsen, Peter; MacNeil, Jessica R.; Patel, Manisha; Bhavsar, Tina; Cohn, Amanda C.; Dinitz-Sklar, Jill; Duffy, Jonathan; Finnie, Janet; Garon, Denise; Hary, Robert; Hu, Fang; Kamiya, Hajime; Kim, Hye-Joo; Kolligian, John; Neglia, Janet; Oakley, Judith; Wagner, Jacqueline; Wagner, Kathy; Wang, Xin; Yu, Yon; Montana, Barbara; Tan, Christina; Izzo, Robin; Clark, Thomas A.;
    Published:
    May 2015
    Source:
    Pediatrics. 135(5):798-804.
    Description:
    Background : In 2013–2014, an outbreak of serogroup B meningococcal disease occurred among persons linked to a New Jersey university (University A). In the absence of a licensed serogroup B meningococcal (MenB) vaccine in the US, the Food and Drug ...
    File Type:
    Filetype[PDF - 365.45 KB]